Investing

Pre-Market Stock News (MAR 27, 2007)

(AMTD) Ameritrade COO Randy MacDonald will retire on June 1, 2007 following the TD Waterhouse clearing conversion.
(AKRX) Akorn signs exclusive distribution agreement with Massachusetts biologic laboratories for tetanus diphtheria vaccine.
(ARXT) Adams Respiratory Therapeutics enters into license and collaboration agreement with MonoSol Rx.
(BCRX) BioCryst Pharm provides Fodosine update; Phase IIb Trial in T-ALL in the treatment of patients with T-cell acute lymphoblastic leukemia/lymphoma voluntarily placed on hold.
(BEBE) Bebe Stores Vice President adopts rule 10b5-1 Trading Plan; selling 80,000 shares over 18 months.
(BTRX) Barrier Therapeutics announces Azoline dose ranging study in tinea versicolor skin fungus meets primary and secondary endpoints; stock down 8%.
(CAMP) CalAmp announces agreement to acquire SmartLink Radio Networks for some $8.1 million plus debt assumption.
(CPHD) Cepheid up 9% after Cramer said to use your Biosite profits to speculate on this diagnostics company.
(CRXX) CominatoRx fell 3% after its rheumatoid arthritis indication compound failed to meet primary endpoints.
(DCX) DaimlerChrysler pushed back its earnings date to May for accounting changes; bids may start coming in next week.
(EQIX) Equinic reiterated 2007 guidance, will boost cap-ex for new 85,000 square foot data center.
(ERIC) Ericsson announced it won two contracts for hosted services by SunCom Wireless, a wireless phone service provider in the southeast of the US, Puerto Rico and the US Virgin Islands.
(FCEL) Fuelcell Tech gets 68 Megawatt pact in Connecticut.
(GHM) Graham awarded $5 million U.S. Gulf Coast Oil Refinery Order.
(HIS) IHS announces that a selling shareholder has priced a 3.75 million share secondary offering at $43.22 per share.
(ISIS) ISIS Pharma says 301012 significantly reduces LDL-C and other harmful lipids and is well Tolerated in multiple Phase 2 studies presented at ACC.
(LEN) Lennar $0.43 EPS vs $0.55e; does not expect to hit 2007 guidance.
(MNOV) MediciNova announces positive clinical results from MN-166 Phase II multiple sclerosis trial.
(MSFT) Microsoft ended up selling 20 million Vista units.
(MVIS) Microvision to develop innovative displays with a global first tier automotive part supplier.
(NUVO) Nuvelo says receives FDA fast track status for rNAPc2 in both first- and second-line treatment of metastatic colorectal cancer.
(OPTM) Optium is paying $35 Million to acquire Kailight Photonics.
(PZZA) Papa Johns plans to open 120 restaurants in China.
(REGN) Regeneron Pharma announced positive interim Phase II data reported for V.E.G.F. Trap-Eye in age-related macular degeneration.
(RMIX) U.S. Concrete announced a joint venture with the Edward Levy Co. that will create the largest ready-mixed concrete producer in the state of Michigan.
(STKL) SunOpta expands supply and strategic exclusive agreements in South America.
(TELN) Telenor selected by NASA for satellite communications modernization contract.
(TGT) Target sees in-line on same store sales in March.
(UCBH) UCBH announced that it is acquiring 100% of Business Development Bank for some $205 million in cash.
(ULBI) Ultralife Battery received a$1.5 million contract from Harris.
(VFC) VF Corp CEO noted as one you can give the benefit of the doubt according to Cramer.
(WMT) Wal-Mart’s Asda unit is considering a bid for Sainsbury in the UK; although others are interested as well and the company may be seeking close to $5.9 Billion.

Jon C. Ogg
March 27, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.